Suppr超能文献

相似文献

1
RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins.
J Mol Biol. 2017 Feb 17;429(4):562-573. doi: 10.1016/j.jmb.2016.11.008. Epub 2016 Nov 16.
3
Characterization of a Ras mutant with identical GDP- and GTP-bound structures .
Biochemistry. 2009 Dec 8;48(48):11449-57. doi: 10.1021/bi901479b.
6
Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
Proteins. 2017 Sep;85(9):1618-1632. doi: 10.1002/prot.25317. Epub 2017 May 31.
7
The structural basis for the transition from Ras-GTP to Ras-GDP.
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12138-42. doi: 10.1073/pnas.192453199. Epub 2002 Sep 4.
8
The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
Science. 1997 Jul 18;277(5324):333-8. doi: 10.1126/science.277.5324.333.
9
Guanosine triphosphatase stimulation of oncogenic Ras mutants.
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7065-70. doi: 10.1073/pnas.96.12.7065.

引用本文的文献

2
Targeting Ras with protein engineering.
Oncotarget. 2023 Jul 1;14:672-687. doi: 10.18632/oncotarget.28469.
3
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.
Signal Transduct Target Ther. 2023 May 23;8(1):212. doi: 10.1038/s41392-023-01441-4.
5
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions.
Antibodies (Basel). 2022 Jul 18;11(3):49. doi: 10.3390/antib11030049.
6
Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S).
Nat Chem Biol. 2022 Nov;18(11):1177-1183. doi: 10.1038/s41589-022-01065-9. Epub 2022 Jul 21.
7
Engineering and exploiting synthetic allostery of NanoLuc luciferase.
Nat Commun. 2022 Feb 10;13(1):789. doi: 10.1038/s41467-022-28425-2.
8
Targeting the "undruggable" RAS with biologics.
Adv Cancer Res. 2022;153:237-266. doi: 10.1016/bs.acr.2021.07.006. Epub 2021 Aug 13.
9
Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
J Biol Chem. 2021 Dec;297(6):101353. doi: 10.1016/j.jbc.2021.101353. Epub 2021 Oct 27.
10
Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor.
J Med Chem. 2021 Sep 9;64(17):13038-13053. doi: 10.1021/acs.jmedchem.1c01130. Epub 2021 Aug 20.

本文引用的文献

1
Inhibition of Ras signaling by blocking Ras-effector interactions with cyclic peptides.
Angew Chem Int Ed Engl. 2015 Jun 22;54(26):7602-6. doi: 10.1002/anie.201502763. Epub 2015 May 7.
2
KRAS as a Therapeutic Target.
Clin Cancer Res. 2015 Apr 15;21(8):1797-801. doi: 10.1158/1078-0432.CCR-14-2662.
3
Dragging ras back in the ring.
Cancer Cell. 2014 Mar 17;25(3):272-81. doi: 10.1016/j.ccr.2014.02.017.
4
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
Nature. 2013 Nov 28;503(7477):548-51. doi: 10.1038/nature12796. Epub 2013 Nov 20.
5
Recombinant probes for visualizing endogenous synaptic proteins in living neurons.
Neuron. 2013 Jun 19;78(6):971-85. doi: 10.1016/j.neuron.2013.04.017.
6
Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery.
ACS Chem Biol. 2013 May 17;8(5):967-77. doi: 10.1021/cb300680c. Epub 2013 Mar 8.
7
Single-round, multiplexed antibody mimetic design through mRNA display.
Angew Chem Int Ed Engl. 2012 Dec 7;51(50):12449-53. doi: 10.1002/anie.201207005. Epub 2012 Nov 4.
8
RAS oncogenes: weaving a tumorigenic web.
Nat Rev Cancer. 2011 Oct 13;11(11):761-74. doi: 10.1038/nrc3106.
9
Rapid mRNA-display selection of an IL-6 inhibitor using continuous-flow magnetic separation.
Angew Chem Int Ed Engl. 2011 Aug 29;50(36):8295-8. doi: 10.1002/anie.201101149. Epub 2011 Jul 14.
10
Adnectins: engineered target-binding protein therapeutics.
Protein Eng Des Sel. 2011 Jan;24(1-2):3-9. doi: 10.1093/protein/gzq097. Epub 2010 Nov 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验